Scarica l'app Stockscreener
48.66
1.99%
0.95
Pre-mercato:
49.48
0.82
+1.69%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché HROW Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$47.71
Aprire:
$48.01
Volume 24 ore:
451.18K
Relative Volume:
0.74
Capitalizzazione di mercato:
$1.80B
Reddito:
$154.15M
Utile/perdita netta:
$-33.58M
Rapporto P/E:
-50.69
EPS:
-0.96
Flusso di cassa netto:
$-20.74M
1 W Prestazione:
+3.09%
1M Prestazione:
+4.02%
6M Prestazione:
+44.22%
1 anno Prestazione:
+53.26%
Intervallo 1D:
$46.21
$49.45
Intervallo di 1 settimana:
$45.40
$49.45
Portata 52W:
$20.85
$54.85
Harrow Inc Stock (HROW) Company Profile
Nome
Harrow Inc
Settore
Telefono
615.733.4731
Indirizzo
1A BURTON HILLS BLVD, NASHVILLE, CA
Compare HROW vs TAK, ZTS, HLN, TEVA, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HROW
Harrow Inc
|
48.66 | 1.77B | 154.15M | -33.58M | -20.74M | -0.96 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 57.18B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.67 | 56.47B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.16B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.31 | 40.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
475.85 | 20.37B | 3.13B | 1.27B | 1.12B | 26.39 |
Harrow Inc Stock (HROW) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-11 | Iniziato | Cantor Fitzgerald | Overweight |
| 2025-06-12 | Iniziato | BTIG Research | Buy |
| 2025-06-10 | Iniziato | William Blair | Outperform |
| 2025-02-06 | Iniziato | H.C. Wainwright | Buy |
| 2024-12-04 | Reiterato | B. Riley Securities | Buy |
| 2024-04-11 | Iniziato | Craig Hallum | Buy |
| 2022-09-08 | Ripresa | B. Riley Securities | Buy |
| 2021-10-14 | Ripresa | B. Riley Securities | Buy |
| 2021-09-24 | Iniziato | Aegis Capital | Buy |
| 2021-07-02 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Harrow Inc Borsa (HROW) Ultime notizie
Will Harrow Inc. stock attract more institutional investorsWeekly Trade Report & Weekly High Return Stock Forecasts - mfd.ru
Is Harrow’s (HROW) Reaffirmed 2025 Guidance Quietly Redefining Its Ophthalmic Growth Strategy? - simplywall.st
Harrow Refocuses After ImprimisRx Exit As New CCO Takes Charge - Sahm
A Look At Harrow’s (HROW) Valuation As 2025 Guidance Is Reaffirmed And Regulatory Issues Clear - Yahoo Finance
New York State Common Retirement Fund Raises Stock Position in Harrow, Inc. $HROW - MarketBeat
B.Riley reiterates Buy rating on Harrow Health stock amid VEVYE growth - Investing.com
Harrow (NASDAQ:HROW) Downgraded by Zacks Research to "Hold" - MarketBeat
Growth Recap: Should I hold or sell Harrow Inc now2025 Breakouts & Breakdowns & AI Enhanced Trading Alerts - baoquankhu1.vn
Harrow Reaffirms FY2025 Revenue Growth Range Of 35% To 40%; Expands Sales Force - Nasdaq
Harrow Stock (+9.7%): Commercial Expansion Ignites Institutional Buying - Trefis
Strength Seen in Harrow (HROW): Can Its 9.7% Jump Turn into More Strength? - Nasdaq
Rival quits California market; OSRX steps in to keep eye meds flowing - stocktitan.net
How Harrow Health Inc. (HROW) Affects Rotational Strategy Timing - Stock Traders Daily
Harrow on track to double sales force, expand product reach By Investing.com - Investing.com Nigeria
OSRX Continues Support in California Market After Competitor Exit - Intellectia AI
Harrow (NASDAQ:HROW) Shares Gap UpShould You Buy? - MarketBeat
Harrow on track to double sales force, expand product reach - Investing.com
(HROW) Harrow Expects 2025 Revenue Range $270M$280M, vs. FactSet Est of $273.4M - marketscreener.com
Harrow Reaffirms 2025 Full-Year Revenue Guidance of $270–$280 Million, Marking Another Year of Strong Growth - marketscreener.com
Is Harrow Inc. attractive for institutional investors2025 Winners & Losers & Verified Momentum Stock Alerts - Mfd.ru
Harrow Becomes Oversold (HROW) - Nasdaq
Can Harrow Inc. be recession proofJuly 2025 Rallies & Daily Volume Surge Signals - mfd.ru
Risk Report: Is PMTV stock showing strong momentum2025 Price Targets & Low Volatility Stock Recommendations - baoquankhu1.vn
109,421 Shares in Harrow, Inc. $HROW Acquired by Blackhawk Capital Partners LLC - MarketBeat
Harrow, Inc. (NASDAQ:HROW) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Harrow: Revisiting This Eyecare Growth Story Ahead Of Q4 Update (NASDAQ:HROW) - Seeking Alpha
Harrow (NASDAQ:HROW) Shares Down 4.4%Time to Sell? - MarketBeat
Market Trends: Can Harrow Inc expand into new marketsJuly 2025 Drop Watch & AI Enhanced Execution Alerts - baoquankhu1.vn
Pharma News: Can Harrow Inc. be recession proofTrade Risk Assessment & Weekly High Return Stock Forecasts - baoquankhu1.vn
Investment Recap: Can OptimizeRx Corporation weather a recessionQuarterly Trade Review & Weekly Setup with ROI Potential - baoquankhu1.vn
Breakeven Is Near for Harrow, Inc. (NASDAQ:HROW) - Yahoo Finance
Assessing Harrow (HROW) Valuation After Its Shift To An Integrated U.S. Eye Care Pharma Platform - Sahm
LJI Wealth Management LLC Makes New Investment in Harrow, Inc. $HROW - MarketBeat
Opaleye management sells $711,814 worth of Harrow shares - MSN
Harrow announces leadership changes, Andrew Boll to serve as President and CFO - MSN
Harrow, Inc. (NASDAQ:HROW) Could Be Less Than A Year Away From Profitability - 富途资讯
Here's What Could Help Harrow (HROW) Maintain Its Recent Price Strength - sharewise.com
Harrow, Inc. (HROW): A Bull Case Theory - Finviz
Zacks Research Upgrades Harrow (NASDAQ:HROW) to "Strong-Buy" - MarketBeat
Gap Down: Can Harrow Inc maintain sales growthBull Run & Safe Capital Allocation Plans - baoquankhu1.vn
Panic Selling: What are the future prospects of Harrow IncTrade Exit Summary & Real-Time Volume Analysis - baoquankhu1.vn
Harrow: Flirting With Missing 2025 Revised Guidance (NASDAQ:HROW) - Seeking Alpha
Value Recap: Will Harrow Inc benefit from geopolitical trendsWeekly Trend Summary & Weekly Momentum Stock Picks - baoquankhu1.vn
Responsive Playbooks and the HROW Inflection - Stock Traders Daily
Institution Moves: Is Harrow Inc stock attractive for ETFsTrade Analysis Summary & Low Drawdown Investment Strategies - moha.gov.vn
Harrow Stock (-8.3%): Major Holder Sale Near Highs Sparks Distribution - Trefis
Evaluating Harrow (HROW) After Recent Share Price Swings And Long Term Return Strength - simplywall.st
Harrow Inc Azioni (HROW) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.21%
0.15%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):